ALGN Align Technology, Inc.
Healthcare$163.55-0.04%ClosedMarket Cap: $11.71B
As of 2026-05-26
Valuation
P/E (TTM)
30.27
PEG
—
P/B
2.82
P/S
2.86
EV/EBITDA
13.31
DCF Value
$87.02
FCF Yield
5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.7%
Operating Margin
14.4%
Net Margin
10.5%
ROE
10.7%
ROA
6.8%
ROIC
9.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.04B | 70.8% | $172.7M | $112.8M | $— | — |
| Q4 null | $1.05B | 65.7% | $159.6M | $135.8M | $— | — |
| FY null | $4.03B | 68.3% | $616.2M | $410.4M | $— | — |
| Q3 null | $995.7M | 64.2% | $96.3M | $56.8M | $— | — |
| Q2 null | $1.01B | 69.9% | $163.0M | $124.6M | $— | — |
| Q1 null | $979.3M | 69.5% | $131.1M | $93.2M | $— | — |
| Q4 null | $995.2M | 70.0% | $144.1M | $103.8M | $— | — |
| FY null | $4.00B | 70.0% | $607.6M | $421.4M | $— | — |
| Q3 null | $977.9M | 69.7% | $162.3M | $116.0M | $— | — |
| Q2 null | $1.03B | 70.3% | $147.0M | $96.6M | $— | — |
| Q1 null | $997.4M | 70.0% | $154.1M | $105.0M | $— | — |
| Q4 2023 | $956.7M | 70.0% | $171.5M | $124.0M | $1.64 | — |